Search Page

1

Cite

Share

Case-control Indian buffet process identifies biomarkers of response to Codrituzumab.

Pradier MF, Reis B, Jukofsky L, Milletti F, Ohtomo T, Perez-Cruz F, Puig O. Pradier MF, et al. Among authors: ohtomo t. BMC Cancer. 2019 Mar 28;19(1):278. doi: 10.1186/s12885-019-5472-0. BMC Cancer. 2019. PMID: 30922327 Free PMC article. Clinical Trial.

Cite

Share

2

Cite

Share

Incorporating Unstructured Patient Narratives and Health Insurance Claims Data in Pharmacovigilance: Natural Language Processing Analysis of Patient-Generated Texts About Systemic Lupus Erythematosus.

Matsuda S, Ohtomo T, Tomizawa S, Miyano Y, Mogi M, Kuriki H, Nakayama T, Watanabe S. Matsuda S, et al. Among authors: ohtomo t. JMIR Public Health Surveill. 2021 Jun 29;7(6):e29238. doi: 10.2196/29238. JMIR Public Health Surveill. 2021. PMID: 34255719 Free PMC article.

Cite

Share

3

Cite

Share

I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma.

Carrasquillo JA, O'Donoghue JA, Beylergil V, Ruan S, Pandit-Taskar N, Larson SM, Smith-Jones PM, Lyashchenko SK, Ohishi N, Ohtomo T, Abou-Alfa GK. Carrasquillo JA, et al. Among authors: ohtomo t. EJNMMI Res. 2018 Mar 5;8(1):20. doi: 10.1186/s13550-018-0374-8. EJNMMI Res. 2018. PMID: 29508107 Free PMC article.

Cite

Share

4

Cite

Share

Circulating biomarkers in hepatocellular carcinoma.

Morris KL, Tugwood JD, Khoja L, Lancashire M, Sloane R, Burt D, Shenjere P, Zhou C, Hodgson C, Ohtomo T, Katoh A, Ishiguro T, Valle JW, Dive C. Morris KL, et al. Among authors: ohtomo t. Cancer Chemother Pharmacol. 2014 Aug;74(2):323-32. doi: 10.1007/s00280-014-2508-7. Epub 2014 Jun 13. Cancer Chemother Pharmacol. 2014. PMID: 24923562

Cite

Share

5

Cite

Share

Intratumoral reciprocal expression of monocarboxylate transporter 4 and glypican-3 in hepatocellular carcinomas.

Yorita K, Ohno A, Nishida T, Kondo K, Ohtomo T, Kataoka H. Yorita K, et al. Among authors: ohtomo t. BMC Res Notes. 2019 Nov 9;12(1):741. doi: 10.1186/s13104-019-4778-y. BMC Res Notes. 2019. PMID: 31706332 Free PMC article.

Cite

Share

6

Cite

Share

Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma.

Kaseb AO, Hassan M, Lacin S, Abdel-Wahab R, Amin HM, Shalaby A, Wolff RA, Yao J, Rashid A, Vennapusa B, Feng J, Ohtomo T. Kaseb AO, et al. Among authors: ohtomo t. Oncotarget. 2016 Oct 25;7(43):69916-69926. doi: 10.18632/oncotarget.12066. Oncotarget. 2016. PMID: 27655712 Free PMC article.

Cite

Share

7

Cite

Share

Syntaxin 17 promotes lipid droplet formation by regulating the distribution of acyl-CoA synthetase 3.

Kimura H, Arasaki K, Ohsaki Y, Fujimoto T, Ohtomo T, Yamada J, Tagaya M. Kimura H, et al. Among authors: ohtomo t. J Lipid Res. 2018 May;59(5):805-819. doi: 10.1194/jlr.M081679. Epub 2018 Mar 16. J Lipid Res. 2018. PMID: 29549094 Free PMC article.

Cite

Share

8

Cite

Share

Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.

Nakamura M, Xu C, Diack C, Ohishi N, Lee RM, Iida S, Kawanishi T, Ohtomo T, Abou-Alfa GK, Chen YC. Nakamura M, et al. Among authors: ohtomo t. Br J Clin Pharmacol. 2018 May;84(5):944-951. doi: 10.1111/bcp.13530. Epub 2018 Mar 9. Br J Clin Pharmacol. 2018. PMID: 29381229 Free PMC article. Clinical Trial.

Cite

Share

9

Cite

Share

Critical role of CD44 in antigen-induced Th2- but not Th17-madiated murine airway inflammation.

Nishimura T, Katoh S, Mori A, Ohtomo T, Saeki M, Hiroi T, Kaminuma O. Nishimura T, et al. Among authors: ohtomo t. Allergol Int. 2016 Sep;65 Suppl:S59-61. doi: 10.1016/j.alit.2016.04.010. Epub 2016 Jul 7. Allergol Int. 2016. PMID: 27210029 Free article. No abstract available.

Cite

Share

10

Cite

Share

Identification of acyl-CoA thioesterase in mouse mesenteric lymph nodes.

Ohtomo T, Nakao C, Sumiya M, Kaminuma O, Abe A, Mori A, Inaba N, Kato T, Yamada J. Ohtomo T, et al. Biol Pharm Bull. 2013;36(5):866-71. doi: 10.1248/bpb.b12-01088. Biol Pharm Bull. 2013. PMID: 23649344 Free article.

Cite

Share